Master in Regulation and Evaluation of Medicines and Health Products

Seminar II



Learning outcomes

The Seminar courses aim to promote in depth knowledge and capacitation of students to have action in the great areas of regulatory sciences, but also to allow students to acquire new knowledge that accurately reflect the state of the art, that as suffered a significant evolution in the last years. By completing this course, the student will be able to: i) identify the core questions that currently define the strategy for regulatory sciences at the service of medicines and health products; ii) identify the current controversies and stakeholders, and; iii) to understand, conceive and develop a critical opinion concerning the aspects presented and discussed.


Medicines Evaluation and Health Technology Assessment in Europe. National System for HTA evaluation. Effectiveness and Comparative Effectiveness. Drug and medical devices risk management-national and European perspective.